Primary hyperaldosteronism, also known as Conn’s syndrome, is a condition where the adrenal glands release too much aldosterone. Aldosterone is a hormone that helps the body balance salt and water by controlling how much sodium is retained and how much potassium is removed by the kidneys. In primary hyperaldosteronism, this hormone is produced in excess without regulation.
The result is that the kidneys hold on to more sodium and water than the body needs, increasing blood volume and raising blood pressure. At the same time, too much potassium is lost in the urine, which can lead to low potassium levels in the blood (hypokalaemia). While it can occur at any age, primary hyperaldosteronism is an important cause of high blood pressure in younger adults and is a recognised contributor to resistant hypertension, where blood pressure remains high despite the use of standard medications. It has been shown to be the cause of 5 percent of hypertension and is reversible.

Primary hyperaldosteronism develops when one or both adrenal glands produce aldosterone in an uncontrolled way. The most common causes are:
Less common causes include a single enlarged adrenal gland without a visible tumour, cancer of the adrenal gland, or inherited forms where genetic changes cause the adrenal tissue to overproduce aldosterone.
Regardless of the cause, the overproduction is “primary” because it originates in the adrenal glands themselves, rather than being driven by another condition elsewhere in the body. Identifying the underlying cause is important, as treatment may differ depending on whether one or both glands are involved.
Primary hyperaldosteronism does not always cause obvious symptoms, and some people are diagnosed only after routine blood pressure checks or blood tests. The condition’s effects come mainly from two factors: raised blood pressure and low potassium levels.
Common signs and symptoms include:
In many cases, people feel well and have no symptoms apart from raised blood pressure, which is why screening for primary hyperaldosteronism is important in certain groups, particularly younger patients with unexplained or resistant hypertension.
Primary hyperaldosteronism can occur in many different patient groups, but some are at a higher likelihood of having the condition. In Singapore, these risk factors are consistent with international guidelines, and recognising them is important for early detection and treatment.
Without proper treatment, primary hyperaldosteronism can lead to serious long-term health problems. Persistent excess aldosterone not only keeps blood pressure high but also directly damages the heart, blood vessels, and kidneys.
Diagnosing primary hyperaldosteronism involves confirming that the adrenal glands are producing excess aldosterone and determining the underlying cause. This process usually takes place in stages, beginning with screening tests and followed by confirmatory assessments.
If primary hyperaldosteronism is not diagnosed and treated early, the continued excess of aldosterone can have lasting effects on multiple organ systems. These effects result from both sustained high blood pressure and the direct harmful actions of aldosterone on the heart, blood vessels, and kidneys.
Treatment for primary hyperaldosteronism aims to correct the excess aldosterone production, normalise blood pressure, restore potassium balance, and reduce long-term cardiovascular and kidney risks. The approach depends on whether one or both adrenal glands are affected.
Primary hyperaldosteronism is a hormonal condition where the adrenal glands produce excess aldosterone, leading to high blood pressure and sometimes low potassium levels. It can be caused by an adrenal growth, enlargement of one or both glands, or inherited factors, and is a significant cause of hypertension in younger adults.
If you are experiencing persistent high blood pressure, especially at a young age, or have been told you have low potassium, schedule a consultation with us for a thorough assessment and tailored treatment plan.
In many cases, yes. If it’s caused by a single overactive adrenal gland, surgery can cure primary hyperaldosteronism. For bilateral disease, medication can control symptoms and prevent long-term damage.
No. While low potassium is a classic sign, many people with primary hyperaldosteronism have normal potassium levels, which means the condition can go undiagnosed without proper screening.
Yes. Primary hyperaldosteronism during pregnancy can make blood pressure harder to control and may increase risks for both mother and baby, so close monitoring by a specialist is important.
Some rare types of primary hyperaldosteronism are inherited due to genetic changes. If a close family member has the condition, screening may be recommended even without symptoms.
A low-salt diet supports treatment for primary hyperaldosteronism by helping control blood pressure and reducing fluid retention, though it cannot replace medical or surgical therapy.
Blood pressure may improve within weeks after surgery or starting medication for primary hyperaldosteronism, but full stabilisation can take several months.
Recurrence is rare after successful surgery for primary hyperaldosteronism, but ongoing follow-up is important to monitor blood pressure and hormone levels, especially in bilateral disease.
Yes. Even with similar blood pressure readings, people with untreated primary hyperaldosteronism have a higher risk of stroke compared to those with essential hypertension, due to the direct harmful effects of aldosterone.

MBBS (Hons), FRACP (Australia)
Dr Dinesh graduated with honours from Monash University, Melbourne in 2009, receiving the Prince Henry's Prize in Surgery. During his endocrinology training in Melbourne, he won the top registrar award at the Endocrine Society of Australia Clinical Weekend in 2016, followed by securing Australia's only Andrology fellowship in 2017. Upon returning to Singapore, he was the sub-speciality lead for adrenal, pituitary, and bone services at Khoo Teck Puat Hospital and established The Metabolic Bone Clinic.
A passionate educator, he served as Associate Programme Director for Endocrinology at NHG, training the next generation of endocrinologists, and received the NHG Teaching Award for Senior Doctors in 2023. An expert endocrinologist with proficiency in both general and sub-speciality endocrinology, he has an interest in longevity through improving cardiovascular risk, metabolism, bone health, and muscle loss prevention, with the ultimate aim of improving the number of healthy years in one's life.

If you’re not achieving your treatment targets, struggling with weight changes, fatigue, or unexplained symptoms—it’s time to take a deeper look.
Get clarity with a tailored plan built around you and improving your metabolic health.
MONDAY - FRIDAY
8:30 am to 5:30 pm
SATURDAY
8:30 am – 12:30 pm
Closed on Sun and PH
© 2026 The Metabolic Clinic. All rights reserved.